Avalo Share Price

Avalo Share Price

NASDAQ: AVTX | Micro Cap | Healthcare
$6.71
-$0.42 (-5.89%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Avalo Stock Performance

Open
$7.08
Prev. Close
$7.13
Circuit Range
N/A
Day Range
$6.69 - $7.10
Year Range
$6.55 - $24.23
Volume
86,303
Average Traded
$6.86

Avalo Share Price Today

As of 19 November 2026, Avalo Therapeutics, Inc.'s share price is $6.71. The stock opened at $7.08, compared to its previous close of $7.13. During today's trading session, Avalo Therapeutics, Inc.'s share price traded between $6.69 and $7.10, with an average price of $6.89. Over the past 52 weeks, the stock has recorded a high of $24.23 and a low of $6.55. In terms of performance, Avalo Therapeutics, Inc.'s share price has declined by 57.88% over the last six months and is down 64.81% on a year-on-year basis.

Avalo Share Price Chart

Line chart of the Avalo price trend over the selected period. The price fell overall, ranging from 6.69 to 7.08, ending at 6.71.
$6.69$7.10
L
Show Current Price
H

Avalo Stock Fundamentals & Key Indicators

Market Cap
$89.95M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.53
Revenue (TTM)
$60.00M
Return On Equity (TTM)
-20.31%
Profit Margin
-130433.33%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-38.12%

Avalo Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.06$0.00$0.00$0.00
Net Profit-$13.72-$19.63-$36.36-$18.95
Net Profit Margin-22866.67%N/AN/AN/A
Income ChangeN/A-43.08%-85.23%47.88%

Avalo Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$18.05$1.92$0.44$0.06
Net Profit-$41.66-$31.54-$35.13-$78.26
Net Profit Margin-230.80%-1642.71%-7984.09%-130433.33%
Income ChangeN/A24.29%-11.38%-122.77%

Avalo Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets11.1711.8412.616.95
Current Assets105.29138.898.416.42
Total Assets116.46150.7320.9933.37
Non Current Liabilities20.4710.749.0722.17
Current Liabilities12.946.964.6222.11
Total Liabilities33.4117.713.6944.28
Shareholders' Equity83.05133.037.3-10.92

Avalo Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-51.46-49.06-30.68-26.75
Investing-81.720.36-0.13-0.1
Financing14.59175.8525.04-14.7

Corporate Actions

Split
Ex-date: 29 Dec 2023

Split
Ex-date: 08 Jul 2022

About Avalo

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.

Avalo Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$7.24
$6.69
-6.50%
Oct 2026
$15.38
$7.16
-53.36%
Sep 2026
$19.64
$15.34
-23.51%
Aug 2026
$18.07
$20.05
+9.89%
Jul 2026
$18.64
$18.25
-1.19%
Jun 2026
$15.90
$18.47
+15.94%
May 2026
$13.43
$15.93
+18.79%
Apr 2026
$15.10
$13.41
-10.72%
Mar 2026
$16.91
$15.02
-14.56%
Feb 2026
$15.78
$17.58
+16.23%
Jan 2026
$17.75
$15.13
-16.64%
Dec 2025
$18.50
$18.14
-4.85%

Avalo Share Price FAQs